Pharmaceutical Litigation

According to recent studies, 70 percent of Americans take at least one prescription drug, and more than half of all Americans take two or more medications. As much as a quarter of the population takes five or more prescription drugs.

These medications are intended to help with medical problems and improve health. Unfortunately, some drugs do more harm than good. Some medications cause dangerous unexpected side effects or even death.

The Burnett Law Firm’s Houston dangerous drug attorneys have decades of collective experience standing up to big drug companies on behalf of those who have been harmed by medications. In class-action lawsuits, multi-district litigation and individual lawsuits, our attorneys have helped clients get the justice they deserve from the drug companies that hurt them. Contact us today to find out how we can help you.

Meet Burnett Law Firm

Experience. Competence. Compassion. Those are a few of the things you can expect from the lawyers at the Burnett Law Firm. Our attorneys know that your case is the most important. That’s why we treat you with the respect you deserve while aggressively standing up for your legal rights. Get to know us better by reading our profiles, or just give us a call.

Lawsuits over Dangerous Medications

Pharmaceutical companies are expected to put new medications through extensive lab tests and clinical trials in order to determine if the drugs are safe and to identify any potential side effects that may arise.

When the Food and Drug Administration (FDA) approves a new medication, the FDA depends on drug companies to provide accurate data and information from clinical trials and other independent studies. The FDA does not have the time, resources or obligation to test medications itself. The duty falls largely on drug companies to ensure they do not endanger the public.

Because it is the job of drug companies to test their medications and ensure they are safe, these companies may be held responsible if a drug turns out to be dangerous. Drug companies are strictly liable, which means that even when a company doesn’t do anything wrong, it may still be held accountable if a medicine causes illness or injury.  These strict liability rules exist because drug companies are in the best possible position to prevent harm, which means that they must have a strong incentive to protect the patients who use their products.

Under strict liability rules, injured victims may pursue a claim simply by proving that the medication harmed them even though they used it as intended. The experienced pharmaceutical litigation attorneys at the Burnett Law Firm can help people recover the compensation they deserve if they have been hurt by medications.

Our defective drug lawyers are not afraid to take on tough cases against some of the biggest pharmaceutical manufacturers in the United States. Riley L. Burnett, Jr., has represented clients who have suffered complications due to many different drugs, including Vioxx, Fen-Phen, Avandia and others. Today, Mr. Burnett and the other attorneys at the Burnett Law Firm handle a wide variety of pharmaceutical injury claims. The firm’s main focus is on birth defects cases arising from the use of SSRI medications.

Bleeding Caused by Xarelto

Xarelto is an anticoagulant (blood-thinner) that belongs to a class of drugs called factor Xa inhibitors. It is produced by Janssen Pharmaceuticals, a Johnson & Johnson subsidiary, under licenses from Bayer.

Xarelto is intended to prevent the formation of blood clots without the constant monitoring required with other blood-thinners. Unfortunately, Xarelto does not have any emergency antidote if uncontrollable bleeding occurs while a patient is on the medication. Other anticoagulants can have their effects reversed if a patient begins to bleed.

Serious organ damage or even death could result from uncontrolled bleeding associated with Xarelto. It is particularly dangerous if the bleeding occurs near important organs like the lungs, kidneys or the brain, or if there is uncontrolled internal bleeding.

Possible side effects of Xarelto include:

  • Unexpected bleeding or bleeding that lasts a long time, such as frequent nose bleeds, unusual bleeding from the gums, menstrual bleeding that is heavier than normal or vaginal bleeding
  • Bleeding that is severe or uncontrollable
  • Urine that is red, pink or brown
  • Bright red or black stools that look like tar
  • Coughing up blood or blood clots
  • Vomiting blood or vomit that looks like coffee grounds
  • Headaches, dizziness or weakness
  • Pain, swelling or new drainage at wound sites

Some patients who took Xarelto and suffered severe complications – and the families of patients who died – have brought claims against the drug’s manufacturer, arguing that they did not receive proper warnings about the drug’s dangerous side effects. You may have a claim for compensation if you or a loved one has suffered negative consequences from taking Xarelto.

Hurt by a Dangerous Drug? Our Lawyers Can Help

When a child develops a birth defect due to SSRI drugs, a lifetime of care may be required and the family may suffer devastating losses. The Burnett Law Firm can help families take action to recover compensation from the drug company that was responsible for the birth defect.

You may have the right to compensation for medical bills, lost wages, pain and suffering, emotional distress, wrongful death or other economic and non-financial losses.

To learn more or to schedule a free consultation to have your pharmaceutical injury case evaluated, call the Burnett Law Firm or contact us online today.

Sources:

  • British Medical Journal – Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study
  • The New England Journal of Medicine – Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
  • The New England Journal of Medicine – Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects.
  • The New England Journal of Medicine – First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
  • British Medical Journal – Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.
Tap to Call Directions